Scientists are testing a new injectable therapy that could help repair brain damage after a stroke, offering fresh hope for reducing long-term disability caused by the condition.
The experimental treatment, developed by researchers at Northwestern University, is delivered through the bloodstream and designed to cross the blood–brain barrier; a natural protective shield that has long made treating brain injuries especially difficult.
A stroke happens when blood flow to part of the brain is blocked, cutting off oxygen and nutrients and causing brain cells to die. Doctors work quickly to restore circulation, but that sudden return of blood flow( known as reperfusion) can trigger inflammation and further damage to already vulnerable brain tissue.
In a new preclinical study, researchers tested the therapy in mice with ischaemic stroke, the most common type of stroke in humans. A single intravenous dose was administered immediately after blood flow was restored.
The results were encouraging. Mice that received the injection showed significantly less brain damage than those that did not. Researchers also found no evidence of toxicity or harmful side effects in major organs.
The study, published in the journal Neurotherapeutics, suggests the therapy could eventually be used alongside existing stroke treatments to reduce secondary injury and support recovery.
The injection is built from supramolecular therapeutic peptides, tiny, self-assembling molecular structures that respond to biological signals in the body. The technology was developed by Northwestern researcher Samuel I. Stupp and gained international attention in 2021, when a related version helped reverse paralysis and repair tissue in mice with severe spinal cord injuries.
Until now, similar treatments required direct injection into damaged tissue. The latest research shows that these dynamic molecules can be delivered through the bloodstream, potentially avoiding invasive procedures.
“This technology has shown remarkable promise in spinal cord injury,” said Stupp, a professor of materials science, engineering, medicine and biomedical engineering at Northwestern University. “Now we’re seeing that it can be applied to stroke and delivered systemically.”
Severe strokes often leave patients with lasting disabilities that affect mobility, independence and cognitive function. The impact extends beyond patients themselves, placing emotional and financial strain on families and healthcare systems.
“There’s a significant personal and societal burden associated with stroke-related disability,” Stupp said. “A therapy that helps limit injury and support recovery could make a meaningful difference over the long term.”
Researchers caution that more studies are needed to determine whether the treatment improves long-term brain function and cognitive outcomes. Many stroke survivors experience ongoing cognitive decline in the months following a stroke.
The team is also exploring whether additional regenerative signals could be added to the therapy to enhance its effects.
While the treatment remains in the experimental stage, scientists say the findings mark an important step toward new ways of helping the brain heal after stroke.
